What is MGF?
Mechano Growth Factor () is a splice variant of the insulin-like growth factor-1 (
MGF (Mechano Growth Factor) — IGF-1 splice variant with local myogenic effect
In short
Isoform of IGF-1 expressed under mechanical stress, studied in models of muscle hypertrophy and regeneration.
Overview
Mechano Growth Factor () is a splice variant of the insulin-like growth factor-1 (
acts independently of systemic receptors to stimulate the proliferation of mononucleated myoblasts. Mechanical overload triggers the alternative splicing of the gene to produce locally. This peptide signals dormant satellite cells to enter the cell cycle and multiply. The expanded pool of satellite cells then provides the necessary nuclei for muscle fiber repair and growth.
Molecular information
Research indications
Grouped by area. Each entry reflects a separate published hypothesis or clinical signal - not medical advice.
Hill & Goldspink (J Anat 2003) - local administration raises muscle mass 20-30% over 14 days in model studies.
Дългосрочният профил на безопасност все още не е установен. Използвайте само под медицинско наблюдение. Може да причини локално подуване, зачервяване или дразнене на мястото на инжектиране. Теоретичен риск от насърчаване на нерегулиран клетъчен растеж поради пролиферативния му механизъм. Потенциал за лека хипогликемия, ако се прилага в прекомерни дози. Не се препоръчва за лица с анамнеза за активни злокачествени заболявания.
3 peer-reviewed sources
References
Links to peer-reviewed publications on PubMed, cited in the peptide's scientific profile.
Hill & Goldspink
Animal | locally | 14 days | Muscle mass +20-30%
J Anat · 2003
View the studyInformation about MGF is based on published scientific research and is intended for research purposes only. Not medical advice.
Products are for in vitro laboratory research only. Not approved for human consumption.
Other peptides
5-Amino-1MQ
5-Amino-1MQ is a small-molecule selective inhibitor of NNMT (nicotinamide N-methyltransferase), identified by Anthony Sauve (Cornell) in 2018. NNMT is a "metabolic sink" for methyl donors and NAD+ — suppressing it in adipocytes raises energy expenditure without reducing calorie intake.
ReadAdipotide
Adipotide is a target peptide developed by Wadih Arap and Renata Pasqualini (MD Anderson) for selective elimination of white adipose tissue. It binds prohibitin on adipocyte vasculature and induces apoptosis of the blood vessels supplying fat tissue — leading to nonsurgical fat reduction.
ReadAOD-9604
AOD-9604 is a modified C-terminal 16-amino-acid fragment of human growth hormone (177-191), supplemented with a tyrosine residue. Retains the lipolytic effect of the full molecule but without diabetogenic or GH-stimulating activity. Developed by Metabolic Pharmaceuticals (Australia) in the 1990s.
ReadARA-290
ARA-290 (Cibinetide) is an 11-amino-acid fragment of erythropoietin (EPO) developed by Anthony Cerami as a cytoprotective molecule without erythropoietic activity. It retains the tissue-protective effects of EPO without raising hematocrit — explaining its potential in diabetic neuropathy and cardiac applications.
ReadArgireline
Argireline is a synthetic acetylated hexapeptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) derived from SNAP-25 — the SNARE complex subunit mediating acetylcholine release at neuromuscular junctions. Topical application reduces muscle activity in expression areas — which is why Argireline is marketed as a "topical Botox alternative".
ReadBPC-157
BPC-157 is a 15-amino-acid fragment isolated from a protective protein in human gastric juice — hence the name Body Protection Compound. Over thirty years of research by Predrag Sikiric's group at the University of Zagreb (100+ peer-reviewed papers) establish its angiogenic action through the VEGFR2 receptor and its stimulation of fibroblasts. If you work with in vitro models of tendon, muscle or gut tissue, BPC-157 is among the most extensively documented regenerative peptides.
ReadEducation
No comments yet. Be the first.
Comments are reviewed before publishing.